The number of companies with approved products and measurable revenues in the field of cell therapy and tissue engineering has exceeded the expectation of many (though not all) in the industry. Markets such as cell/tissue are often characterized by overestimated evaluations of commercial potential and underestimated consideration of the actual challenges. Indeed many technology challenges [...]
Tissue engineering involves taking either autologous, allogeneic or xenogeneic cells and redirecting those cells to carry out fundamental processes. Often the researcher will use a biomaterial matrix and seed the cells into this matrix. The redirection may take the form of stimulating the cells to become stem cells or precursor cells, or it may mean [...]
Publishing a new report in December 2009: Tissue Engineering, Cell Therapy and Transplantation: Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018. This report examines the status of technologies, applications and markets for tissue engineering, cell therapy and tissue/cell transplantation. The report reviews therapeutic tissue engineering, tissue reconstruction, cell therapies, tissue/organ [...]
Discussed in a press release from the University of Virginia Health System, "Aritificial Pancreas Proves Effective in Treating Type 1 Diabetes Overnight in Pilot Study." Researchers at the University of Virginia Health System are reporting remarkable results from their pilot clinical study of the artificial pancreas, a computerized, subcutaneous system that could one day revolutionize the [...]
The applications for cell therapy (stem or otherwise) continue to expand in very diverse ways. I found this development particularly interesting — the use of stem cells in a "cell bandage" for use in the treatment of osteoarthritis. The company is Azellon, Ltd. Prof Anthony Hollander from the University of Bristol in the UK, has [...]
Researchers at the Salk Intitute for Biological Studies have demonstrated that a technology to correct the genetic defect in human disease and induce cell differentiation at the site of the manifested disease is feasible, an achievement demonstrated previously only in mice. In the May 31, 2009, edition of Nature, Salk reseachers published their findings [...]
New medical technologies represented in specific companies recently added (September 2008) to the Medtech Startups Database: Recombinant proteins and cells for intervertebral disc cell regeneration Non-hydrogel polymer used to stimulate tissue growth in dental/orthopedic applications Biomaterials and biologics for repair of bone and cartilage Portable endoscopic imaging Device treatments for restless leg syndrome (RLS) Disposable [...]
Contact:
